In the latest session, Biohaven Ltd (NYSE: BHVN) closed at $13.05 down -3.33% from its previous closing price of $13.5. In other words, the price has decreased by -$3.33 from its previous closing price. On the day, 1.76 million shares were traded. BHVN stock price reached its highest trading level at $13.5946 during the session, while it also had its lowest trading level at $12.975.
Ratios:
For a deeper understanding of Biohaven Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.33. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.12.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $65.
On September 16, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $57.Jefferies initiated its Buy rating on September 16, 2024, with a $57 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’25 when CHILDS JOHN W bought 32,700 shares for $30.47 per share. The transaction valued at 996,238 led to the insider holds 2,320,571 shares of the business.
CHILDS JOHN W bought 29,000 shares of BHVN for $1,042,393 on Dec 30 ’24. The Director now owns 2,368,741 shares after completing the transaction at $35.94 per share. On Oct 02 ’24, another insider, CHILDS JOHN W, who serves as the Director of the company, bought 21,052 shares for $47.50 each. As a result, the insider paid 999,970 and bolstered with 21,052 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHVN now has a Market Capitalization of 1378523776 and an Enterprise Value of 1045331456.
Stock Price History:
The Beta on a monthly basis for BHVN is 3.46, which has changed by -0.66042155 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, BHVN has reached a high of $55.70, while it has fallen to a 52-week low of $13.04. The 50-Day Moving Average of the stock is -12.16%, while the 200-Day Moving Average is calculated to be -58.10%.
Shares Statistics:
For the past three months, BHVN has traded an average of 2.05M shares per day and 1555300 over the past ten days. A total of 102.10M shares are outstanding, with a floating share count of 89.17M. Insiders hold about 12.68% of the company’s shares, while institutions hold 88.84% stake in the company. Shares short for BHVN as of 1752537600 were 13484329 with a Short Ratio of 6.59, compared to 1749772800 on 10882006. Therefore, it implies a Short% of Shares Outstanding of 13484329 and a Short% of Float of 14.92.
Earnings Estimates
The dynamic stock of Biohaven Ltd (BHVN) is currently attracting attention from 4.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$1.31, with high estimates of -$1.07 and low estimates of -$1.47.
Analysts are recommending an EPS of between -$4.88 and -$6.47 for the fiscal current year, implying an average EPS of -$5.86. EPS for the following year is -$5.72, with 5.0 analysts recommending between -$4.23 and -$8.77.
Revenue Estimates
Based on 14 analysts’ estimates, the company’s revenue will be $119.6M in the next fiscal year. The high estimate is $215.28M and the low estimate is $30.34M.
